Close

Leerink Partners Reiterates Outperform on Jazz Pharmaceuticals (JAZZ) as Investor Concerns Grow

Go back to Leerink Partners Reiterates Outperform on Jazz Pharmaceuticals (JAZZ) as Investor Concerns Grow
JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) Delayed: 108.32 --0 (-0%)
Previous Close $108.32    52 Week High $160.00 
Open $108.32    52 Week Low $95.80 
Day High $108.32    P/E 20.13 
Day Low $108.32    EPS $5.38 
Volume 1,216